Supernus Pharmaceuticals, Inc. financial data

Symbol
SUPN on Nasdaq
Industry
Pharmaceutical Preparations
Location
9715 Key West Avenue, Rockville, MD
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 25, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 204 % +41.6%
Quick Ratio 21.7 % -1.23%
Debt-to-equity 35.7 % -34.1%
Return On Equity 7.52 % +5139%
Return On Assets 5.54 % +5847%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 55.8M shares +1.53%
Common Stock, Shares, Outstanding 55.7M shares +1.86%
Entity Public Float 1.41B USD
Common Stock, Value, Issued 56K USD +1.82%
Weighted Average Number of Shares Outstanding, Basic 55.1M shares +1.03%
Weighted Average Number of Shares Outstanding, Diluted 56M shares +0.81%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 662M USD +8.94%
Research and Development Expense 109M USD +18.8%
Costs and Expenses 580M USD -5.33%
Operating Income (Loss) 81.7M USD
Nonoperating Income (Expense) 16.2M USD +102%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 97.9M USD +3434%
Income Tax Expense (Benefit) 24M USD +1552%
Net Income (Loss) Attributable to Parent 73.9M USD +5513%
Earnings Per Share, Basic 1.34 USD/shares +6600%
Earnings Per Share, Diluted 1.32 USD/shares +6500%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 69.3M USD -7.63%
Accounts Receivable, after Allowance for Credit Loss, Current 142M USD -1.44%
Inventory, Net 54.3M USD -29.9%
Assets, Current 686M USD +39.1%
Property, Plant and Equipment, Net 11.5M USD -14.7%
Operating Lease, Right-of-Use Asset 24.5M USD -15.6%
Intangible Assets, Net (Excluding Goodwill) 522M USD -13%
Goodwill 117M USD 0%
Other Assets, Noncurrent 31.5M USD -15.9%
Assets 1.37B USD +7.08%
Accounts Payable, Current 4.59M USD +134%
Employee-related Liabilities, Current 21.2M USD +2.43%
Accrued Liabilities, Current 76.4M USD -4.04%
Liabilities, Current 292M USD +0.76%
Deferred Income Tax Liabilities, Net 4.96M USD -80.1%
Operating Lease, Liability, Noncurrent 27.4M USD -17.5%
Other Liabilities, Noncurrent 7.6M USD +18.3%
Liabilities 332M USD -6.69%
Accumulated Other Comprehensive Income (Loss), Net of Tax -189K USD +68.1%
Retained Earnings (Accumulated Deficit) 556M USD +15.3%
Stockholders' Equity Attributable to Parent 1.04B USD +12.4%
Liabilities and Equity 1.37B USD +7.08%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 38.4M USD -21.8%
Net Cash Provided by (Used in) Financing Activities 1.57M USD -98%
Net Cash Provided by (Used in) Investing Activities -51.6M USD -122%
Common Stock, Shares Authorized 130M shares 0%
Common Stock, Shares, Issued 55.7M shares +1.86%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.7M USD -103%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 69.3M USD -7.63%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 66.7M USD +9.63%
Deferred Tax Assets, Gross 199M USD +3.79%
Operating Lease, Liability 34.3M USD -17.5%
Payments to Acquire Property, Plant, and Equipment 248K USD -10.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 74.3M USD +1788%
Lessee, Operating Lease, Liability, to be Paid 40M USD
Property, Plant and Equipment, Gross 29.4M USD +1.57%
Operating Lease, Liability, Current 6.89M USD -17.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.96M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 8.23M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) -5.48M USD -1160%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.73M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.74M USD
Deferred Tax Assets, Operating Loss Carryforwards 93.1M USD -8.11%
Unrecognized Tax Benefits 5.84M USD +172%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3M USD
Operating Lease, Payments 4M USD +15.8%
Additional Paid in Capital 479M USD +9.09%
Amortization of Intangible Assets 78M USD -5.35%
Depreciation, Depletion and Amortization 20.7M USD +0.72%
Deferred Tax Assets, Net of Valuation Allowance 133M USD +1.09%
Share-based Payment Arrangement, Expense 27.8M USD +3.72%
Interest Expense 0 USD -100%